Flammer Martina M.D.'s Form 4 filing
INSMED Inc (INSM) · filed Sep 4, 2025
- Accession no.
- 0001796960-25-000004
- Filed
- Sep 4, 2025
- Trade date
- Sep 2, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions and 8 derivative transactions. Open-market sales total $26.9M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flammer Martina M.D.CIK 0001796960 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Common Stock | MOption exerciseAcquired | +13,680 | $34.03 | +$465,530.4 | 96,791 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseAcquired | +17,160 | $26.46 | +$454,053.6 | 113,951 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseAcquired | +25,710 | $26.43 | +$679,515.3 | 139,661 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseAcquired | +38,846 | $17.07 | +$663,101.22 | 178,507 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseAcquired | +13,072 | $19.74 | +$258,041.28 | 191,579 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseAcquired | +36,555 | $18.95 | +$692,717.25 | 228,134 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseAcquired | +23,835 | $29.13 | +$694,313.55 | 251,969 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseAcquired | +17,790 | $25.83 | +$459,515.7 | 269,759 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −19,066 | $141.27F2 | −$2,693,453.82 | 250,693 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −5,877 | $142.03F3 | −$834,710.31 | 244,816 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −35,245 | $143.16F4 | −$5,045,674.2 | 209,571 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −28,063 | $144.05F5 | −$4,042,475.15 | 181,508 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −63,782 | $145.33F6 | −$9,269,438.06 | 117,726 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −34,615 | $146.05F7 | −$5,055,520.75 | 83,111 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −13,680 | $0.00 | $0 | 0 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −17,160 | $0.00 | $0 | 0 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −25,710 | $0.00 | $0 | 8,570 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −38,846 | $0.00 | $0 | 25,898 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −13,072 | $0.00 | $0 | 13,073 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −36,555 | $0.00 | $0 | 73,110 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −23,835 | $0.00 | $0 | 39,725 | Direct | |
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −17,790 | $0.00 | $0 | 53,370 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 19,066 shares sold at prices ranging from $140.56 to $141.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F3
This is the weighted average sales price representing 5,877 shares sold at prices ranging from $141.61 to $142.55 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 35,245 shares sold at prices ranging from $142.70 to $143.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F5
This is the weighted average sales price representing 28,063 shares sold at prices ranging from $143.70 to $144.63 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F6
This is the weighted average sales price representing 63,782 shares sold at prices ranging from $144.70 to $145.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F7
This is the weighted average sales price representing 34,615 shares sold at prices ranging from $145.70 to $146.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney